Research Summary
Research Summary
01/29/2025
Kate Young
Neoadjuvant nivolumab plus ipilimumab demonstrated improved event-free survival, higher pathologic complete response rates, and lower toxicity compared with chemotherapy in patients with resectable...
01/29/2025
FDA Alert
FDA Alert
01/28/2025
Anthony Calabro, MA
The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...
01/28/2025
Conference Coverage
Conference Coverage
04/26/2023
Anthony Calabro, MA
In their presentation at the 48th ONS Congress, in San Antonio, Texas, Kathy Waitman DNP, APN-BC, AOCNP and Shaunna Kersten CNS, MSN, ANP identified the best imaging modalities based on common oncologic...
04/26/2023
Metastatic Lung Cancer
Metastatic Lung Cancer
12/07/2022
The FDA-approved treatment combines tremelimumab, durvalumab, and platinum-based chemotherapy, and follows a randomized trial.
12/07/2022
Screening
Screening
06/30/2022
In a new study, investigators examined the impact of the expanded lung cancer screening criteria on the mortality rate of high-risk patient populations.
06/30/2022
Lung Cancer Screening
Lung Cancer Screening
07/15/2021
The American College of Chest Physicians has released new guidelines on screening patients for lung cancer after a review of current literature was performed.
07/15/2021
Lung Cancer Screening
Lung Cancer Screening
03/10/2021
The US Preventive Services Task Force has updated its recommendations on who and when to screen for lung cancer.
03/10/2021
FDA
FDA
12/21/2020
This roundup of recent FDA approvals details the authorization of a new COVID-19 vaccine and options for lung and prostate cancer.
12/21/2020
Screening
Screening
10/06/2020
The American Thoracic Society has released a scientific statement addressing disparities in lung cancer screening eligibility and focusing on barriers to screening and strategies to improve screening rates...
10/06/2020
Lung cancer
Lung cancer
10/25/2018
Individuals who use angiotensin converting enzyme inhibitors (ACE
10/25/2018